Startseite › Krebs (alle Arten) › Ohio › Columbus
Klinische Studien zu Krebs (alle Arten) in Columbus, OH
38 Studien zu Krebs (alle Arten) suchen Teilnehmer an Standorten in und um Columbus (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Teilnehmer gesuchtPhase 1/2
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
Teilnehmer gesuchtBeobachtungsstudie
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Teilnehmer gesuchtPhase 3
- The Ohio State University, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Teilnehmer gesuchtBeobachtungsstudie
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Teilnehmer gesuchtPhase 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Teilnehmer gesuchtPhase 3
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
Teilnehmer gesuchtPhase 2
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Teilnehmer gesuchtPhase 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Teilnehmer gesuchtPhase 2
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Teilnehmer gesuchtPhase 2
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- und 8 weitere
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Teilnehmer gesuchtPhase 2
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Teilnehmer gesucht
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Teilnehmer gesuchtPhase 1/2
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Teilnehmer gesuchtPhase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Teilnehmer gesuchtPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Teilnehmer gesuchtPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Teilnehmer gesuchtPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Teilnehmer gesuchtPhase 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Teilnehmer gesucht
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Teilnehmer gesuchtPhase 2
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
Teilnehmer gesucht
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Teilnehmer gesuchtPhase 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Teilnehmer gesuchtBeobachtungsstudie
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Teilnehmer gesucht
- Ohio State University Comprehensive Cancer Center, Columbus
Krebs (alle Arten)-Studien in anderen Städten
- Houston, TX121 Studien
- New York City, NY110 Studien
- Boston, MA86 Studien
- Los Angeles, CA73 Studien
- Nashville, TN65 Studien
- Philadelphia, PA59 Studien
- Durham, NC58 Studien
- Washington, DC58 Studien
- Chicago, IL51 Studien
- Seattle, WA49 Studien
- Atlanta, GA49 Studien
- Arlington, VA48 Studien
Weitere Studien in Columbus
- Nichtkleinzelliges Lungenkarzinom56 Studien
- Brustkrebs39 Studien
- Eierstockkrebs39 Studien
- Lungenkrebs37 Studien
- Akute myeloische Leukämie35 Studien
- Chronische lymphatische Leukämie28 Studien
- Metastasierender Krebs27 Studien
- Endometriumkarzinom25 Studien
- Kolorektales Karzinom24 Studien
- Prostatakrebs24 Studien
- Multiples Myelom24 Studien
- Melanom21 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.